Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 March 27, 2026 8:30 ...
12h
Rocket Pharmaceuticals Wins FDA Accelerated Approval for KRESLADI Gene Therapy in Severe LAD-I Kids
Rocket Pharmaceuticals (NASDAQ:RCKT) said the U.S. Food and Drug Administration has granted accelerated approval to KRESLADI ...
Published in the journal Fire, the study titled “Artificial Intelligence for Geospatial Decision Support in Rural Wildfire Management: A Configurational Mapping Review” provides a systematic analysis ...
The global automotive cybersecurity market is growing rapidly, expected to be valued at around US$ 4,050.3 million in 2026 ...
Discover what AgentScope from Alibaba is, how it supports multi agent systems, memory, tools, voice, MCP and production ...
Oracle has launched new agentic AI innovations for Oracle AI Database that will help customers rapidly build, deploy, and ...
Accenture, leveraging Anthropic’s Claude AI, launched Cyber.AI to transform cybersecurity with real-time AI-driven operations ...
AI agents don't knock before entering. Most of the security team doesn't know they're there.
While 6G is anticipated to take off commercially by 2030, the work-back schedule reveals a tight timeline for wireless ...
Certain companies have stock prices that immediately make logical sense because their earnings are increasing, their margins ...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated biotechnology company advancing a sustainable pipeline of ...
AI coding assistants have unleashed new superpowers for developers, with the likes of GitHub Copilot, Cursor’s AI code editor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results